Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome

Bibliographic Details
Main Authors:	Tschernatsch, M, Ashraf, S, Willcox, N, Blaes, F, Kaps, M, Vincent, A, Lang, B
Format:	Journal article
Published:	2009

Similar Items

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
by: Lang, B, et al.
Published: (2003)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
by: Lorenzoni, P, et al.
Published: (2008)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
by: Vincent, A
Published: (2008)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
by: Lang, B
Published: (2007)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
by: Cruz, M, et al.
Published: (2005)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
by: Lang, B, et al.
Published: (2013)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
by: Bain, P, et al.
Published: (1996)

Spontaneously resolving paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome in association with treatment-sensitive Lambert-Eaton myasthenic syndrome
by: Simister, R, et al.
Published: (2006)

Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
by: Rozsa, C, et al.
Published: (2008)

Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
by: Simister, R, et al.
Published: (2011)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
by: Palace, J, et al.
Published: (2004)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
by: Lang, B, et al.
Published: (2008)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
by: Motomura, M, et al.
Published: (1997)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
by: Titulaer, M, et al.
Published: (2010)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
by: Titulaer, M, et al.
Published: (2011)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
by: Maddison, P, et al.
Published: (2001)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
by: Squier, M, et al.
Published: (1991)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
by: Maddison, P, et al.
Published: (2011)

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
by: Payne, M, et al.
Published: (2010)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
by: Lehnerer, S, et al.
Published: (2024)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
by: Wirtz, P, et al.
Published: (2005)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
by: Wirtz, P, et al.
Published: (2005)

IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
by: Beck, S, et al.
Published: (2007)

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
by: Wirtz, P, et al.
Published: (2003)

Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
by: Spillane, J, et al.
Published: (2015)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
by: Pinto, A, et al.
Published: (2002)

Paraneoplastic syndromes secondary to neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2010)

Clinical characteristics of Lambert-Eaton myasthenic syndrome with positive P/Q-type voltage-gated calcium channel antibody
by: Tan, Y, et al.
Published: (2021)

Autoantibodies in childhood opsoclonus-myoclonus syndrome.
by: Blaes, F, et al.
Published: (2008)

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
by: Bradbury, P, et al.
Published: (2004)

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
by: Bradbury, P, et al.
Published: (2004)

The isolation and characterisation of the genes coding for the calcium channel affected by Lambert-Eaton myasthenic syndrome antibodies in NG108-15 cells
by: von Rosch, A
Published: (1992)

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
by: Titulaer, M, et al.
Published: (2011)

Synaptotagmin 2 Mutations Cause an Autosomal-Dominant Form of Lambert-Eaton Myasthenic Syndrome and Nonprogressive Motor Neuropathy
by: Herrmann, David N., et al.
Published: (2017)

A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility.
by: Knowles, C, et al.
Published: (2002)

A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility
by: Knowles, C, et al.
Published: (2001)

Successful 'passive transfer' of paraneoplastic stiff person syndrome with antibodies to an intracellular antigen.
by: Vincent, A
Published: (2010)

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
by: Graus, F, et al.
Published: (2005)

Antibodies associated with paraneoplastic neurological disorders.
by: Vincent, A
Published: (2005)

THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS
by: Maddison, P, et al.
Published: (2012)